ID: ALA4761197

Max Phase: Preclinical

Molecular Formula: C17H14O3

Molecular Weight: 266.30

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc(/C=C2\Cc3ccccc3C2=O)ccc1O

Standard InChI:  InChI=1S/C17H14O3/c1-20-16-9-11(6-7-15(16)18)8-13-10-12-4-2-3-5-14(12)17(13)19/h2-9,18H,10H2,1H3/b13-8+

Standard InChI Key:  QNLJZHBIIUWWIF-MDWZMJQESA-N

Associated Targets(Human)

Carboxylesterase 2 583 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pancreatic triacylglycerol lipase 476 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 266.30Molecular Weight (Monoisotopic): 266.0943AlogP: 3.22#Rotatable Bonds: 2
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.48CX Basic pKa: CX LogP: 3.43CX LogD: 3.43
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.85Np Likeness Score: 0.29

References

1. Huo PC,Hu Q,Shu S,Zhou QH,He RJ,Hou J,Guan XQ,Tu DZ,Hou XD,Liu P,Zhang N,Liu ZG,Ge GB.  (2021)  Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors.,  29  [PMID:33214035] [10.1016/j.bmc.2020.115853]
2. Huo PC,Guan XQ,Liu P,Song YQ,Sun MR,He RJ,Zou LW,Xue LJ,Shi JH,Zhang N,Liu ZG,Ge GB.  (2021)  Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors.,  209  [PMID:33007602] [10.1016/j.ejmech.2020.112856]

Source